Grant Skrepnek to Recombinant Proteins
This is a "connection" page, showing publications Grant Skrepnek has written about Recombinant Proteins.
Connection Strength
0.016
-
Peginterferon alfa-2a versus peginterferon alfa-2b as initial treatment of hepatitis C virus infection: a cost-utility analysis from the perspective of the Veterans Affairs Health Care System. Pharmacotherapy. 2007 Jun; 27(6):813-24.
Score: 0.016